{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:41:13Z","timestamp":1789756873396,"version":"4.0.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1097\/01.mao.0000227663.79210.c1","type":"journal-article","created":{"date-parts":[[2006,6,20]],"date-time":"2006-06-20T05:00:56Z","timestamp":1150779656000},"page":"896-900","source":"Crossref","is-referenced-by-count":12,"title":["Factors Relating to the Vertigo Control and Hearing Changes Following Intratympanic Gentamicin for Intractable M\u00e9ni\u00e8re's Disease"],"prefix":"10.1097","volume":"27","author":[{"given":"Arata","family":"Horii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Saika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiko","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suetaka","family":"Nishiike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Mitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munehisa","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisako","family":"Masumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomo","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Kizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-22-20210212","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00005537-200002010-00009","article-title":"Update on intratympanic gentamicin for Meniere's disease.","volume":"110","author":"Blakley","year":"2000","journal-title":"Laryngoscope"},{"key":"R4-22-20210212","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/00005537-200008000-00014","article-title":"Intratympanic gentamicin for the treatment of unilateral Meniere's disease.","volume":"110","author":"Kaplan","year":"2000","journal-title":"Laryngoscope"},{"key":"R5-22-20210212","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00129492-200103000-00016","article-title":"Long-term follow-up of transtympanic gentamicin for Meniere's syndrome.","volume":"22","author":"Harner","year":"2001","journal-title":"Otol Neurotol"},{"key":"R6-22-20210212","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00129492-200407000-00023","article-title":"Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis.","volume":"25","author":"Chia","year":"2004","journal-title":"Otol Neurotol"},{"key":"R7-22-20210212","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/01.mlg.0000149439.43478.24","article-title":"Intratympanic gentamicin for Meniere's disease: a meta-analysis.","volume":"114","author":"Cohen-Kerem","year":"2004","journal-title":"Laryngoscope"},{"key":"R8-22-20210212","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/01.moo.0000134438.91734.38","article-title":"Transtympanic perfusion: indications and limitations.","volume":"12","author":"Light","year":"2004","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"R9-22-20210212","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.physiol.67.040403.120816","article-title":"Endocrinology of the stress response.","volume":"67","author":"Charmandari","year":"2005","journal-title":"Annu Rev Physiol"},{"key":"R10-22-20210212","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0194-5998(95)70102-8","article-title":"Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease.","volume":"113","year":"1995","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R11-22-20210212","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/00016489850183359","article-title":"Intratympanic gentamicin in Meniere's disease.","volume":"118","author":"Kaasinen","year":"1998","journal-title":"Acta Otolaryngol"},{"key":"R12-22-20210212","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00005537-200303000-00013","article-title":"Intratympanic gentamicin for intractable Meniere's disease.","volume":"113","author":"Perez","year":"2003","journal-title":"Laryngoscope"},{"key":"R13-22-20210212","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00129492-200303000-00027","article-title":"Gentamicin perfusion vestibular response and hearing loss.","volume":"24","author":"Light","year":"2003","journal-title":"Otol Neurotol"},{"key":"R15-22-20210212","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0196-0709(85)80013-2","article-title":"Gentamicin tympanoclysis: effects on the vestibular secretory cells.","volume":"6","author":"Pender","year":"1985","journal-title":"Am J Otolaryngol"},{"key":"R16-22-20210212","first-page":"534","article-title":"Electrocochleography and gentamicin therapy for Meniere's disease: a preliminary report.","volume":"21","author":"Adamonis","year":"2000","journal-title":"Am J Otolaryngol"},{"key":"R17-22-20210212","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archotol.129.6.626","article-title":"Effect of parenteral aminoglycoside administration on dark cells in the crista ampullaris.","volume":"129","author":"Cureoglu","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R18-22-20210212","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00005537-200305000-00009","article-title":"Long-term hearing outcome in patients receiving intratympanic gentamicin for Meniere's disease.","volume":"113","author":"Wu","year":"2003","journal-title":"Laryngoscope"}],"container-title":["Otology &amp; Neurotology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mao.0000227663.79210.c1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:42:06Z","timestamp":1785858126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00129492-200609000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mao.0000227663.79210.c1","relation":{},"ISSN":["1531-7129"],"issn-type":[{"value":"1531-7129","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}